Advertisement

Trends in Opioid Use Disorder Among Older Adults: Analyzing Medicare Data, 2013–2018

      Introduction

      Opioid use disorder has grown rapidly over the years and is a public health crisis in the U.S. Although opioid use disorder is widely studied, relatively little is known about it among older adults. The goal of this study is to gain a better understanding of opioid use disorder among older Medicare beneficiaries over time and across several sociodemographic dimensions.

      Methods

      Data from the 2013–2018 Centers for Medicare & Medicaid Services Master Beneficiary Summary Files were analyzed in 2020 to examine the trends in opioid use disorder prevalence among Fee-for-Service Medicare beneficiaries aged ≥65 years. Utilizing the overarching opioid use disorder flag, trends in opioid use disorder prevalence were examined for the following sociodemographic dimensions: age, sex, race/ethnicity, and dual eligibility status (i.e., enrolled in both Medicare and Medicaid owing to low income). Chi-square tests were used to compare opioid use disorder prevalence across groups.

      Results

      Since 2013, estimated rates of opioid use disorder among older adults have increased by >3-fold overall in the U.S. Estimated opioid use disorder is more prevalent among the young–old (i.e., ages 65–69 years) beneficiaries than among other older adults, and dually eligible beneficiaries have consistently shared a heavier burden of opioid use disorder than Medicare-only beneficiaries. Regarding race/ethnicity, Blacks and American Indians/Alaskan Natives are more vulnerable to opioid use disorder than other groups.

      Conclusions

      The descriptive trends between 2013 and 2018 indicate that estimated opioid use disorder prevalence has increased greatly over the study period in all sociodemographic subgroups of older adults, highlighting an urgent challenge for public health professionals and gerontologists.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Jalal H
        • Buchanich JM
        • Roberts MS
        • Balmert LC
        • Zhang K
        • Burke DS
        Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016.
        Science. 2018; 361: eeaau1184https://doi.org/10.1126/science.aau1184
        • Hickton DJ
        • Leary ML
        National heroin task force final report and recommendations.
        U.S. Department of Justice, White House Office of National Drug Control Policy, Washington, DC2015 (justice.gov/file/822231/download. Published December 2015. Accessed August 24, 2020)
        • Hser YI
        • Evans E
        • Grella C
        • Ling W
        • Anglin D
        Long-term course of opioid addiction.
        Harv Rev Psychiatry. 2015; 23: 76-89https://doi.org/10.1097/HRP.0000000000000052
        • Li KJ
        • Smedberg DL
        • DeLisi LE
        A retrospective 4-year outcome study of Veterans admitted to an acute inpatient detoxification unit for opioid use disorder.
        Am J Addict. 2019; 28: 318-323https://doi.org/10.1111/ajad.12893
        • Larochelle MR
        • Bernson D
        • Land T
        • et al.
        Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.
        Ann Intern Med. 2018; 169: 137-145https://doi.org/10.7326/M17-3107
        • Hser YI
        • Mooney LJ
        • Saxon AJ
        • et al.
        High mortality among patients with opioid use disorder in a large healthcare system.
        J Addict Med. 2017; 11: 315-319https://doi.org/10.1097/ADM.0000000000000312
        • Evans E
        • Li L
        • Min J
        • et al.
        Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006–10.
        Addiction. 2015; 110: 996-1005https://doi.org/10.1111/add.12863
        • Case A
        • Deaton A
        Deaths of Despair and the Future of Capitalism.
        Princeton University Press, Princeton, NJ2020
        • Rubin R
        Opioid-related problems increasing among older adults.
        JAMA. 2018; 320: 2067https://doi.org/10.1001/jama.2018.17630
        • West NA
        • Severtson SG
        • Green JL
        • Dart RC
        Trends in abuse and misuse of prescription opioids among older adults.
        Drug Alcohol Depend. 2015; 149: 117-121https://doi.org/10.1016/j.drugalcdep.2015.01.027
        • Carter MW
        • Yang BK
        • Davenport M
        • Kabel A
        Increasing rates of opioid misuse among older adults visiting emergency departments.
        Innov Aging. 2019; 3: igz002https://doi.org/10.1093/geroni/igz002
        • Scholl L
        • Seth P
        • Kariisa M
        • Wilson N
        • Baldwin G
        Drug and opioid-involved overdose deaths—United States, 2013–2017.
        MMWR Morb Mortal Wkly Rep. 2018; 67: 1419-1427https://doi.org/10.15585/mmwr.mm675152e1
      1. Zullo AR, Danko KJ, Moyo P, et al. Prevention, diagnosis, and management of opioids, opioid misuse and opioid use disorder in older adults. Rockville, MD: Agency for Health care Research and Quality. https://effectivehealthcare.ahrq.gov/products/opioids-older-adults/protocol. AHRQ Publication No. 21-EHC005. Published November 2020. Accessed December 10, 2020.

        • Feagin J
        • Bennefield Z
        Systemic racism and U.S. health care.
        Soc Sci Med. 2014; 103: 7-14https://doi.org/10.1016/j.socscimed.2013.09.006
        • Stepanikova I
        • Oates GR
        Perceived discrimination and privilege in health care: the role of socioeconomic status and race.
        Am J Prev Med. 2017; 52: S86-S94https://doi.org/10.1016/j.amepre.2016.09.024